Dr. Beth Latimer discusses the use of advanced treatments for infection-associated neurological conditions, including PANDAS and PANS. She covers the use of NSAIDs, steroids, IVIG, plasmapheresis, and rituximab, highlighting the benefits and risks of each approach. Dr. Latimer emphasizes the importance of identifying and treating any underlying infections, such as Lyme disease or tick-borne illnesses, which can contribute to these conditions. She also notes the complexity and heterogeneity of these disorders, making it challenging to develop standardized treatment protocols. Overall, Dr. Latimer presents a comprehensive overview of the current approaches to managing these complex neurological conditions in children.